retatrutide ly3437943 parkinson's disease clinical trial retatrutide parkinson's disease clinical trial Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update-150cent The Phase 3 Exenatide results

These may be symptoms of gastroparesis (stomach paralysis)

CrossRef Higher Food Inflammation Index Is Linearly Associated With Higher Risk of MASLD: A CrossSectional Study Based on the NHANES (19992020) Qingwan Yang, Xin Cai, Zhenghua Xiao Food Science & Nutrition .2025;[Epub] CrossRef Metabolic Divergence Between MASLD and Metabolic Syndrome: Distinct Clinical Phenotypes and Risk Stratification Implications Mariana M

40 , e3844 (2024)

The most commonly reported side effects of Ozempic may include nausea, vomiting, diarrhea, stomach pain, and constipation

Many people regain weight after stopping abruptly, which is why a planned maintenance strategy gradual dose review, protein and strength-training habits established during therapy, and continued follow-up matters more than the medicine itself

That same mechanism explains why stomach-related symptoms are among the most common complaints, particularly after starting treatment or increasing the dose